GlobeNewswire

The biosensor market is valued at USD 25.5 billion in 2021 and is expected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026

Metal-based nanoparticles can be used effectively to detect nucleic acid sequences by exploiting their optoelectronic properties. Recent advances in nanotechnology have led to the use of nanomaterials, such as metallic nanoparticles, oxide nanoparticles, magnetic nanomaterials, carbonaceous materials, quantum dots, and metallophthalocyanines, to enhance electrochemical signals. biocatalytic events that occur at the electrode / electrolyte interface. .New York, April 19, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Release of the “Biosensors Market with COVID-19 Impact by Type, Product, Technology, Application and Region – Global Forecast to 2026” – https: //www.reportlinker.com/p04838915/?utm_source=GNW Nanomaterials, such as carbon nanotubes and indium oxide nanowires, are widely used to make nanotechnology-based biosensors or nanobiosensors. Nanobiosensors have revolutionized the future of disease diagnosis. They are gaining prominence in areas such as catalysis, optics, biomedical sciences, mechanics, magnetism, and energy science. Cost pressure is negatively affecting the growth of the global POC market, due to reduced reimbursements and lack of sufficient budgets. For example, in 2013, the US government passed the Healthcare Reform Bill, requiring manufacturers to pay a hefty 2.3% annual excise tax on medical devices. Likewise, France has explicitly targeted medical devices to limit costs in order to recover from the recession. France’s 2013 budget included price reductions of around $ 157.6 million on the medical sector (including POC), leading to savings of $ 102.8 million in the outpatient sector and $ 54 , 8 million USD on hospitals. Spending on medical devices (including POC) around the world is also at risk due to a decrease in the list of health products eligible for reimbursement. These factors are putting pressure on the global medical device industry. As a result, manufacturers are finding it increasingly difficult to support prices and prevent margin erosion, with increasing competition. Thus, price reduction measures on medical devices, including POC diagnostics, will pose a major challenge to market growth in the years to come. human body to monitor a range of vital signs and provide specific treatments as needed. Sensor patches are categorized as wearable devices, which have built-in intelligence, connectivity and increased ease of use. Sensor patches provide unique opportunities for status / activity monitoring, feedback and activation / delivery services, such as drug administration or stimulation, tracking, identification, personal pop-up notifications, l information display and virtual assistance. In simpler terms, these devices can monitor, document and augment life, and they can be used to help people with specialized professional and personal activities. These devices also help send messages. information directly to caregivers, as well as to all remote monitoring of patients and detection of diseases at an early stage Bioc Portable sensors: The fastest growing product segment of the biosensor market Portable biosensors have attracted considerable attention due to their potential to change conventional medical diagnostics and continuous health monitoring concepts. Portable biosensor applications aim to change centralized hospital care systems to personal home medicine and reduce the cost of healthcare and diagnostic time. Today, we can see that portable biosensors are bringing a wave of innovation to society. comfort and better usability can provide a new level This availability of real-time data enables better clinical decisions and translates into better health outcomes and more efficient use of health systems For human society, portable biosensors can assist in the early detection of health events and the prevention of hosp italisation. Such events are expected to boost the market g Home diagnostics: the fastest growing application of the biosensor market Home diagnostics is not limited to checking body weight and measuring body temperature during illness , they also include monitoring of health and fitness at home without the intervention of doctors. , fertility, cholesterol, HIV, vitamin D, influenza, and testosterone can be done at home by taking a small sample and loading it into a biosensor units test cartridge. consumer smartphone via Bluetooth, providing instant test results and suggestions for improving health. Home diagnostics offers various advantages, such as privacy, convenience and ease of use, and low cost. North America: The leading region in the global biosensor market. North America is expected to represent the largest Global Biosensors market size from 2021 to 2026.The presence of key industrial players and early adoption of new technological advancements such as nanotechnology are the major growth factors of the North America Biosensors market. research and development of medical devices containing biosensors. Research and development of medical devices is heavily dependent on funding and grants. For example, in 2017, Senseonics Holdings (US), a medical technology company, raised $ 41 million USD to market its Eversense continuous glucose monitoring system and to support research and development for next-generation versions of the sensor. Similarly, in 2016, Endotronix (US), a developer of wireless and implantable pressure sensors, raised $ 32 million as part of a Series C funding round. These investments resulted in the development of biosensors for a range of medical equipment, which has driven the market during the historical period. experts, ranging from component suppliers to Tier 1 companies and OEMs. The distribution of the primary is as follows: • By type of company: Tier 1 – 40%, Tier 2 – 25% and Tier 3 – 35% • By designation: Level C executives – 35%, Directors – 28%, and others – 37% • By region: North America – 48%, Europe – 22%, APAC – 20%, RoW – 10% Abbott (United States), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories , Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors ( Australia), ACON Laboratories, Inc. (United States), CARDEA BIO INC., (United States), Conductive Technologies (United States), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (United States United States), NeuroSky (United States), Pinnacle Technology Inc. (United States), SD Biosensor, INC. (South Korea), VitalConnect (US) and Xsensio (Switzerland) are some of the major players in the biosensor market. : The report segments the biosensor market and forecast its size, in value, based on type (Sen sor Patch, integrated device), product (portable biosensors, non-portable biosensors), technology (electrochemical, optical, piezoelectric, thermal, nanomechanical ), application (POC, home diagnostics, research laboratories, environmental monitoring, food and beverage, biodefense) and region (North America, Europe, APAC and RoW). The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the Biosensors market. The report also covers qualitative aspects in addition to quantitative aspects of these markets Key Benefits of Buying the Report The report will help the leaders / new entrants in this market with information on the closest approximations to the revenue figures for the market global and sub This report will help stakeholders and get more insights to better position their businesses and plan suitable go-to-market strategies.The report also helps stakeholders to understand the pulse of the Biosensors market and provides them with information on the main market drivers, restraints, The report also covers the impact of COVID-19 on the biosensor market. Reportlinker researches and curates the latest industry data so you get all the market research you need – instantly, in one place .__________________________ CONTACT: Clare: [email protected] US: (339) -368- 6001 Intl: + 1339-368 -6001